Low and high molecular weight poly(l‐lysine)s/poly(l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently

Poly(l‐lysine)s, PLLs, are commonly used for DNA compaction and cell transfection. We report that, although PLLs of low (2.9 kDa), L‐PLL, and high (27.4 kDa), H‐PLL, Mw in free form and DNA‐complexed cannot only cause rapid plasma membrane damage in human cell lines, phosphatidylserine “scrambling” and loss of membrane integrity, but later (24 h) initiate stress‐induced cell death via mitochondrial permeabilization without the involvement of processed caspase‐2. Mitochondrially mediated apoptosis was confirmed by detection of cytochrome c (Cyt c) release, activation of caspases‐9 and ‐3, and subsequent changes in mitochondrial membrane potential. Plasma membrane damage and apoptosis were most prominent with H‐PLL. Cytoplasmic level of Cyt c was more elevated following H‐PLL treatment, but unlike L‐PLL case, inhibition of Bax channel‐forming activity reduced the extent of Cyt c release from mitochondria by half. Inhibition of Bax channel‐forming activity had no modulatory effect on L‐PLL‐mediated Cyt c release. Further, functional studies of isolated mitochondria indicate that H‐PLL, but not L‐PLL, can directly induce Cyt c release, membrane depolarization, and a progressive decline in the rate of uncoupled respiration. Combined, our data suggest that H‐PLL and L‐PLL are capable of initiating mitochondrially mediated apoptosis differently. The observed PLL‐mediated late‐phase apoptosis may provide an explanation for previously reported transient gene expression associated with PLL‐based transfection vectors. The importance of our data in relation to design of novel and safer cationic non‐viral vectors for human gene therapy is discussed.

[1]  M. Reers,et al.  Inhibition of mitochondrial phospholipase A2 by mono- and dilysocardiolipin. , 1987, Biochemistry.

[2]  S. Smaili,et al.  Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential , 2001, Cell Death and Differentiation.

[3]  I. Enyedy,et al.  Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.

[4]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  John Calvin Reed,et al.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.

[6]  B. Zhivotovsky,et al.  Caspase-2 Permeabilizes the Outer Mitochondrial Membrane and Disrupts the Binding of Cytochrome c to Anionic Phospholipids* , 2004, Journal of Biological Chemistry.

[7]  Seamus J. Martin,et al.  Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity* , 1996, The Journal of Biological Chemistry.

[8]  W. Shier,et al.  Polycations as prostaglandin synthesis inducers. Stimulation of arachidonic acid release and prostaglandin synthesis in cultured fibroblasts by poly(L-lysine) and other synthetic polycations. , 1984, Biochimica et biophysica acta.

[9]  K. Ulbrich,et al.  A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression , 2000, Gene Therapy.

[10]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  Daniel G. Anderson,et al.  Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Daniel G. Anderson,et al.  Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[14]  B. Zhivotovsky,et al.  Processed caspase‐2 can induce mitochondria‐mediated apoptosis independently of its enzymatic activity , 2004, EMBO Reports.

[15]  B. Antonsson,et al.  3,6-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulation. , 2003, Journal of medicinal chemistry.

[16]  V. Natarajan,et al.  Activation of endothelial cell phospholipase D by polycations. , 1997, The American journal of physiology.

[17]  D W Pack,et al.  Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. W. Pack,et al.  On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  D. Newmeyer,et al.  Mitochondria Releasing Power for Life and Unleashing the Machineries of Death , 2003, Cell.

[20]  Mark H Ellisman,et al.  Disruption of Mitochondrial Function during Apoptosis Is Mediated by Caspase Cleavage of the p75 Subunit of Complex I of the Electron Transport Chain , 2004, Cell.

[21]  C H Wu,et al.  Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. , 1987, The Journal of biological chemistry.

[22]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[23]  Martin L Read,et al.  Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. , 2001, Blood.

[24]  K. Ulbrich,et al.  Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo , 2002, The journal of gene medicine.

[25]  K. Ulbrich,et al.  Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. , 1999, Bioconjugate chemistry.

[26]  C. Caldarera,et al.  Polyamines directly induce release of cytochrome c from heart mitochondria. , 2000, Biochemical Journal.

[27]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[28]  C. Caldarera,et al.  Spermine triggers the activation of caspase‐3 in a cell‐free model of apoptosis , 1999, FEBS letters.

[29]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  P. Briand,et al.  Intracellular rate-limiting steps of gene transfer using glycosylated polylysines in cystic fibrosis airway epithelial cells , 2002, Gene Therapy.

[31]  J. Martinou,et al.  Pro-apoptotic Bid induces membrane perturbation by inserting selected lysolipids into the bilayer. , 2005, The Biochemical journal.

[32]  Takuro Niidome,et al.  In vitro gene transfection using dendritic poly(L-lysine). , 2002, Bioconjugate chemistry.